Zhejiang Apeloa Kangyu Pharmaceutical
China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
✓ HC GMP (4)
Quick Facts: Zhejiang Apeloa Kangyu Pharmaceutical
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- China
- Website
- https://apeloa.com/
- Modalities
- Small Molecule API
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Zhejiang Apeloa Kangyu Pharmaceutical
Zhejiang Apeloa Kangyu Pharmaceutical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://apeloa.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Zhejiang Apeloa Kangyu Pharmaceutical FDA Inspection History
2023-07
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2023-07-28 |
Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
Jinhua
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Nov 01, 2026
Japan-accredited overseas site (PMDA)
general (non-sterile) · 2 sites
- Dongyang, China · Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd. (2 sites) — general (non-sterile) · valid to Jun 23, 2030
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 31, 2026
Frequently Asked Questions About Zhejiang Apeloa Kangyu Pharmaceutical
How many FDA inspections does Zhejiang Apeloa Kangyu Pharmaceutical have on record?
CDMO Signal tracks 1 FDA inspection for Zhejiang Apeloa Kangyu Pharmaceutical, sourced from the FDA inspection database. See the full inspection history above.
Has Zhejiang Apeloa Kangyu Pharmaceutical received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Zhejiang Apeloa Kangyu Pharmaceutical.
Does Zhejiang Apeloa Kangyu Pharmaceutical have a CDMO Signal Score?
Not yet. Zhejiang Apeloa Kangyu Pharmaceutical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Zhejiang Apeloa Kangyu Pharmaceutical for a manufacturing program?
Use the free AI matchmaker to compare Zhejiang Apeloa Kangyu Pharmaceutical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Asymchem Laboratories (Tianjin)
China
Small Molecule API, Peptides & Oligos
Changzhou Pharmaceutical Factory
China
Small Molecule API, Oral Solid Dose
Changzhou SynTheAll Pharmaceutical (WuXi STA)
China
Small Molecule API, Peptides & Oligos
Zhejiang Jiuzhou Pharmaceutical
China
Small Molecule API
Qilu Animal Health
Jinan, Shandong, China
Veterinary, Small Molecule API, Sterile Injectables, Oral Liquids, Powders & Premixes, Vaccines
Compare Zhejiang Apeloa Kangyu Pharmaceutical with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.